Usa Financial Portformulas Corp adds Henry Schein (HSIC) to its portfolio

Henry Schein (HSIC) : Usa Financial Portformulas Corp added new position in Henry Schein during the most recent quarter end. The investment management firm now holds 55,174 shares of Henry Schein which is valued at $9,129,090 , the company said in a statement filed on Aug 15, 2016 with the SEC.Henry Schein makes up approximately 2.45% of Usa Financial Portformulas Corp’s portfolio.

Other Hedge Funds, Including , Highland Capital Management Lp reduced its stake in HSIC by selling 19,800 shares or 38.08% in the most recent quarter. The Hedge Fund company now holds 32,200 shares of HSIC which is valued at $5,327,812. Henry Schein makes up approx 0.29% of Highland Capital Management Lp’s portfolio.Alpine Woods Capital Investors reduced its stake in HSIC by selling 62 shares or 0.25% in the most recent quarter. The Hedge Fund company now holds 25,073 shares of HSIC which is valued at $4,148,579. Henry Schein makes up approx 0.24% of Alpine Woods Capital Investors’s portfolio. Moors Cabot sold out all of its stake in HSIC during the most recent quarter. The investment firm sold 1,985 shares of HSIC which is valued $332,408.Blair William Coil boosted its stake in HSIC in the latest quarter, The investment management firm added 583 additional shares and now holds a total of 12,070 shares of Henry Schein which is valued at $2,021,242. Henry Schein makes up approx 0.02% of Blair William Coil’s portfolio.Dekabank Deutsche Girozentrale boosted its stake in HSIC in the latest quarter, The investment management firm added 1,900 additional shares and now holds a total of 68,578 shares of Henry Schein which is valued at $11,449,783. Henry Schein makes up approx 0.12% of Dekabank Deutsche Girozentrale’s portfolio.

Henry Schein closed down -0.81 points or -0.49% at $162.98 with 3,41,373 shares getting traded on Thursday. Post opening the session at $163.92, the shares hit an intraday low of $162.28 and an intraday high of $164.31 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Henry Schein reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $1.63. The company had revenue of $2872.60 million for the quarter, compared to analysts expectations of $2845.09 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.

Leave a Reply

Henry Schein - Is it time to Sell?

Top Brokerage Firms are advising their investors on Henry Schein. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.